QIPT
Quipt Home Medical Corp.
NASDAQ · Healthcare · Medical - Devices · US
$3.65
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 285.3M | 341.4M | 245.9M | 211.7M | 139.9M |
| Cost of Revenue | 11.1M | 6.1M | 68.9M | 57.9M | 33.2M |
| Gross Profit | 253.9M | 239.3M | 177.0M | 153.8M | 106.6M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 116.8M | 97.5M | 94.7M | 82.4M | 53.8M |
| General & Admin Expense | 100.8M | 91.9M | 89.2M | 78.2M | 51.7M |
| Selling & Marketing Expense | 6.0M | 5.6M | 5.5M | 4.2M | 2.2M |
| Other Expenses | 101.8M | 154.4M | 81.2M | 68.6M | 48.1M |
| Total Operating Expenses | 218.6M | 251.9M | 175.9M | 150.9M | 101.9M |
| Cost and Expenses | 288.2M | 346.7M | 244.8M | 208.8M | 135.1M |
| Operating Income (EBIT) | (3.2M) | (5.3M) | 1.1M | 5.8M | 4.7M |
| Non-Operating | |||||
| Interest Income | 376.2K | 467.0K | 791.5K | 366.3K | — |
| Interest Expense | 8.6M | 6.7M | 9.3M | 7.6M | 1.9M |
| Net Interest Income | (8.3M) | (6.3M) | (8.6M) | (7.2M) | (1.9M) |
| Other Non-Op Income/Expense | (6.7M) | (9.1M) | (7.8M) | — | (1.8M) |
| Non-Operating Income (excl Interest) | 35.0K | — | 601.0K | 829.9K | (283.0K) |
| EBT (Pre-Tax Income) | (10.0M) | (14.4M) | (6.7M) | (2.7M) | 2.9M |
| Income Tax Expense | 236.0K | 241.0K | 109.0K | 85.0K | (1.9M) |
| Bottom Line | |||||
| Net Income | (10.7M) | (10.7M) | (6.8M) | (2.8M) | 4.8M |
| Earnings from Cont. Ops | (10.2M) | (10.6M) | (6.8M) | (2.8M) | 4.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (10.7M) | (10.7M) | (6.8M) | (2.8M) | 4.8M |
| Per Share | |||||
| Basic EPS | ($0.25) | ($0.25) | ($0.16) | ($0.07) | $0.14 |
| Diluted EPS | ($0.25) | ($0.25) | ($0.16) | ($0.07) | $0.13 |
| Revenue Per Share | $6.54 | $7.89 | $5.79 | $5.32 | $4.05 |
| Shares | |||||
| Basic Shares Outstanding | 43.6M | 43.3M | 42.5M | 39.8M | 34.6M |
| Diluted Shares Outstanding | 43.6M | 43.3M | 42.5M | 39.8M | 37.2M |
| Profitability Metrics | |||||
| EBITDA | 46.5M | 57.4M | 51.1M | 45.1M | 28.1M |
| D&A | 48.9M | 63.3M | 50.6M | 40.2M | 23.0M |
| EBIT | (2.5M) | (5.9M) | 514.0K | 4.9M | 5.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025